Zacks Investment Research upgraded shares of Triple-S Management (NYSE:GTS) from a hold rating to a buy rating in a research report report published on Wednesday morning, Zacks.com reports. They currently have $28.00 target price on the stock.
According to Zacks, “Triple-S Management Corporation is an independent licensee of the Blue Cross Blue Shield Association. It is the largest managed care company in Puerto Rico, serving approximately one million members across all regions. Triple-S offers a broad portfolio of managed care and related products in the commercial, Medicare and Reform (similar to Medicaid) markets. In addition to its managed care business, Triple-S provides life and property and casualty insurance in Puerto Rico. “
Separately, ValuEngine lowered shares of Zynerba Pharmaceuticals from a buy rating to a hold rating in a research report on Tuesday, May 28th.
Shares of NYSE GTS opened at $24.74 on Wednesday. The company has a debt-to-equity ratio of 0.03, a quick ratio of 0.60 and a current ratio of 0.60. The firm has a market capitalization of $568.41 million, a P/E ratio of -16.06, a price-to-earnings-growth ratio of 1.09 and a beta of 0.26. Triple-S Management has a 12 month low of $15.45 and a 12 month high of $39.07. The business’s 50-day simple moving average is $24.12.
Triple-S Management (NYSE:GTS) last posted its quarterly earnings results on Thursday, May 9th. The company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.51. The company had revenue of $787.59 million for the quarter, compared to the consensus estimate of $769.21 million. Triple-S Management had a negative net margin of 1.06% and a positive return on equity of 1.88%. The firm’s quarterly revenue was up 2.3% compared to the same quarter last year. During the same period last year, the company posted $0.60 EPS. As a group, equities research analysts forecast that Triple-S Management will post 2.25 EPS for the current year.
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Barclays PLC raised its position in Triple-S Management by 3.4% in the fourth quarter. Barclays PLC now owns 23,542 shares of the company’s stock valued at $409,000 after purchasing an additional 775 shares during the last quarter. Investors Research Corp raised its holdings in Triple-S Management by 31.3% in the 2nd quarter. Investors Research Corp now owns 4,200 shares of the company’s stock valued at $100,000 after buying an additional 1,000 shares during the last quarter. Citigroup Inc. raised its holdings in Triple-S Management by 15.2% in the 4th quarter. Citigroup Inc. now owns 9,359 shares of the company’s stock valued at $163,000 after buying an additional 1,232 shares during the last quarter. Bank of America Corp DE raised its holdings in Triple-S Management by 15.9% in the 4th quarter. Bank of America Corp DE now owns 11,468 shares of the company’s stock valued at $199,000 after buying an additional 1,574 shares during the last quarter. Finally, BNP Paribas Arbitrage SA boosted its position in Triple-S Management by 418.7% during the 1st quarter. BNP Paribas Arbitrage SA now owns 4,554 shares of the company’s stock worth $104,000 after buying an additional 3,676 shares during the period. 82.41% of the stock is currently owned by institutional investors.
Triple-S Management Company Profile
Triple-S Management Corporation, through its subsidiaries, provides a portfolio of managed care and related products in the commercial, Medicare Advantage, and Medicaid markets. It operates through three segments: Managed Care, Life Insurance, and Property and Casualty Insurance. The company offers various managed care products, including health maintenance organization plans; preferred provider organization plans; BlueCard program; Medicare Supplement products; Medicare Advantage products; Medicaid plans; and claims processing and other administrative services to employers, professional and trade associations, individuals, and government entities.
Recommended Story: What is the formula for the cash asset ratio?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Triple-S Management Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Triple-S Management and related companies with MarketBeat.com's FREE daily email newsletter.